# Acute Lymphoblastic Leukemia research **Type:** Topics **Canonical URL:** https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/ ## Facts | Field | Value | | --- | --- | | Description | This cluster of papers focuses on the epidemiology, genetic basis, treatment, and outcomes of childhood acute lymphoblastic leukemia (ALL). It covers topics such as genetic alterations, minimal residual disease, pharmacogenomics, prognostic factors, and relapse risk. The papers also discuss the challenges and advancements in pediatric oncology for the treatment of childhood leukemia. | | Domain | Health Sciences | | Field | Medicine | | OpenAlex ID | t10950 | | Works | 271 | ## Topic papers all Showing 15 of 271. - [Cancer treatment and survivorship statistics, 2016](https://scholariq.org/papers/cancer-treatment-and-survivorship-statistics-2016/) - [Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia](https://scholariq.org/papers/tisagenlecleucel-in-children-and-young-adults-with-b-cell-lymphoblastic-leukemia/) - [Chronic Health Conditions in Adult Survivors of Childhood Cancer](https://scholariq.org/papers/chronic-health-conditions-in-adult-survivors-of-childhood-cancer/) - [T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial](https://scholariq.org/papers/t-cells-expressing-cd19-chimeric-antigen-receptors-for-acute-lymphoblastic/) - [International incidence of childhood cancer, 2001–10: a population-based registry study](https://scholariq.org/papers/international-incidence-of-childhood-cancer-2001-10-a-population-based-registry/) - [Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis](https://scholariq.org/papers/analysis-of-flt3-activating-mutations-in-979-patients-with-acute-myelogenous/) - [Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma](https://scholariq.org/papers/rituximab-chop-versus-chop-alone-or-with-maintenance-rituximab-in-older-patients/) - [Cancer statistics for adolescents and young adults, 2020](https://scholariq.org/papers/cancer-statistics-for-adolescents-and-young-adults-2020/) - [Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease](https://scholariq.org/papers/standardized-rt-pcr-analysis-of-fusion-gene-transcripts-from-chromosome/) - [Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study](https://scholariq.org/papers/lymphoproliferative-disorders-in-patients-receiving-thiopurines-for-inflammatory/) - [Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study](https://scholariq.org/papers/molecular-response-to-treatment-redefines-all-prognostic-factors-in-children-and/) - [Understanding and Managing Methotrexate Nephrotoxicity](https://scholariq.org/papers/understanding-and-managing-methotrexate-nephrotoxicity/) - [Impact of Prenatal Chlorpyrifos Exposure on Neurodevelopment in the First 3 Years of Life Among Inner-City Children](https://scholariq.org/papers/impact-of-prenatal-chlorpyrifos-exposure-on-neurodevelopment-in-the-first-3/) - [A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial](https://scholariq.org/papers/a-treatment-protocol-for-infants-younger-than-1-year-with-acute-lymphoblastic/) - [High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial](https://scholariq.org/papers/high-dose-methotrexate-with-or-without-whole-brain-radiotherapy-for-primary-cns/) ## Topic primary papers Showing 15 of 83. - [International incidence of childhood cancer, 2001–10: a population-based registry study](https://scholariq.org/papers/international-incidence-of-childhood-cancer-2001-10-a-population-based-registry/) - [Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study](https://scholariq.org/papers/molecular-response-to-treatment-redefines-all-prognostic-factors-in-children-and/) - [A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial](https://scholariq.org/papers/a-treatment-protocol-for-infants-younger-than-1-year-with-acute-lymphoblastic/) - [Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia](https://scholariq.org/papers/results-of-nopho-all2008-treatment-for-patients-aged-1-45-years-with-acute/) - [The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017](https://scholariq.org/papers/the-global-burden-of-childhood-and-adolescent-cancer-in-2017-an-analysis-of-the/) - [Epidemiology and Etiology of Leukemia and Lymphoma](https://scholariq.org/papers/epidemiology-and-etiology-of-leukemia-and-lymphoma/) - [Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion.](https://scholariq.org/papers/transplacental-chemical-exposure-and-risk-of-infant-leukemia-with-mll-gene/) - [Toward a NOTCH1/FBXW7/RAS/PTEN –Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia Study](https://scholariq.org/papers/toward-a-i-notch1-fbxw7-ras-pten-i-based-oncogenetic-risk-classification-of/) - [Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission](https://scholariq.org/papers/bone-marrow-transplants-from-hla-identical-siblings-as-compared-with/) - [Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study](https://scholariq.org/papers/socioeconomic-inequalities-in-cancer-incidence-and-access-to-health-services/) - [Environmental and Genetic Risk Factors for Childhood Leukemia: Appraising the Evidence](https://scholariq.org/papers/environmental-and-genetic-risk-factors-for-childhood-leukemia-appraising-the/) - [Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance](https://scholariq.org/papers/consensus-guideline-for-use-of-glucarpidase-in-patients-with-high-dose/) - [The risk profile of childhood leukaemia in Greece: a nationwide case-control study](https://scholariq.org/papers/the-risk-profile-of-childhood-leukaemia-in-greece-a-nationwide-case-control/) - [Parental Age and Risk of Childhood Cancer](https://scholariq.org/papers/parental-age-and-risk-of-childhood-cancer/) - [Maternal Diet and Infant Leukemia: The DNA Topoisomerase II Inhibitor Hypothesis: A Report from the Children's Oncology Group](https://scholariq.org/papers/maternal-diet-and-infant-leukemia-the-dna-topoisomerase-ii-inhibitor-hypothesis/) --- Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.